Introduction
Chromate compounds (Cr 6þ species) are genotoxic carcinogens (1) . DNA oxidation, DNA strand breaks, DNA-DNA/ DNA-protein/Cr-DNA cross-links, Cr-DNA ternary or monoadducts and formations of abasic lesions or alkali labile sites are the variety of DNA lesions reported following exposure to Cr 6þ (2) . The mechanism of toxicity involves Cr 6þ metabolism and oxidative stress (3) . Free radicals generated during Cr 6þ metabolism contribute to metal genotoxicity and carcinogenesis (4) (5) (6) .
For abrogation of Cr 6þ genotoxicity, several antioxidants viz. N-acetyl-cysteine, pyrrolidine dithiocarbamate, epigallocatechin gallate, vitamin E and vitamin C have been evaluated (7) (8) (9) (10) (11) (12) (13) (14) . However, none have been considered suitable for experimental therapeutics of Cr 6þ toxicity. The impeding factors are low redox potential, relatively less understanding of mechanism of action, mega doses and the nephrotoxic potential in case of vitamin C.
Suitability of LA, a metabolic antioxidant, in this context has never been examined (15) . LA (in reduced form) together with di-hydro lipoic acid (DHLA) forms an ideal antioxidant couple.
LA has high redox potential and can regenerate antioxidants (such as vitamin E, vitamin C and GSH) from their radical or inactive form. LA is an effective antidote against heavy metal toxicity ( [16] [17] [18] [19] . A substantial inhibition of Cr 6þ -induced DNA damage (DNA protein cross-link formation) by LA has been reported by us (19) .
In present study, the suitability of LA for its experimental therapeutic/preventive potential against Cr 6þ -induced DNA damage has been investigated and characterized in mouse peripheral blood mononuclear cells (PBMC) and bone marrow cells (BMC) using single-cell gel electrophoresis (SCGE) (20) . Three regimens of LA administration (viz. pre-, co-and posttoxicant treatment) simulating achievable preventive/therapeutic usage of LA were examined. Reactive oxygen species (ROS) generation and DNA damage during interactions of Cr 6þ with LA was examined using Plasmid Relaxation Assay. Results are of experimental chemotherapeutic/chemopreventive value.
Materials and methods
Agarose and low-melting agarose (LMA) were procured from BRL Life technologies Inc., Gaithersburg, MD and ascorbic acid from BDH Laboratory, Poole, UK. PBS (Ca 2þ , Mg 2þ free), HBSS and Triton X-100 were obtained from Hi-media Pvt. Ltd, Mumbai, India, potassium dichromate (purity ! 99.8%) from Qualigens (Mumbai, India), alpha-lipoic acid (purity ! 98%) from Fluka (Sigma-Aldrich, India) and pUC19 plasmid DNA from Bangalore Genei, Bangalore, India. Ethidium bromide, Na 2 -EDTA, Histopaque-1077 were obtained from Sigma (St Louis, MO, USA). All other chemicals and dyes used were of analytical reagent grade and commercially available.
Animal treatment and preparation of cells Swiss albino mice (male, 20-25 g) were procured from the inbred colony at Indian Institute of Toxicology Research, Lucknow, India, and maintained at standard pellet diet and water ad libitum. Mice were randomized in groups of four animals in each and housed at 25°C with 12-h light-dark cycle period. Potassium dichromate was administered to Swiss albino mice orally ad libitum in drinking water at the concentrations of 10 mg, 20 mg and 50 mg/l, which amounted to an estimated daily intake of 5, 10 or 25 mg/kg body weight (3) based on monitored water consumption. Toxicant was administered for 3 days to set DNA damage in cells, which was characterized in mouse PBMC and BMC using SCGE and analyses of generated comets for Tail moment, Tail DNA and Tail length. DNA damage was dose dependent. Cr 6þ and LA were administered as per the treatment schedule shown in Figure 1 . LA was administered intraperitoneally (in 1:9 ethanol:saline) at the dose of 5, 10 and 25 mg/kg body weight. Potassium dichromate was administered at the dose of 25 mg/kg body weight to set the toxicity. Three treatment regimens of LA viz. pre-, co-and post-toxicant treatment were evaluated. Total treatment period was of 6 days. Animals were sacrificed by cervical dislocation and tissues collected 24 h after the last treatment. Blood was collected through corneal puncture. Marrow was collected from femur. After stripping off skeletal muscles, the bone was cut in middle and marrow flushed out for suspension in ice-cold HBSS-20 mM EDTA-10% DMSO solution. Procedure had ethical clearance from Institutional Animals Ethics Committee.
PBMC were separated on HISTOPAQUE-1077 and suspended in PBS as described earlier (21) . Cell viability was checked using 5,6-carboxyfluresceine dye (22) and found to be 90-95% (data not shown).
SCGE (comet) assay
The assay was performed essentially as recommended (23, 24 -free PBS and distributed onto the end frosted slides for further processing as per conventional method (24) . Samples were processed under dim light and electrophoresed in dark.
Data collection and statistical analysis
Comets were scored using an image analysis system (Kinetic Imaging, Liverpool, UK) that was attached to a fluorescence microscope (Leica, Wetzlar, Germany) equipped with appropriate filters. Microscope was connected to a computer through a charge-coupled device camera to transport images to software (Komet 3.1) for analyses. Final magnification was Â400. The parameters for quantifying DNA damage included Olive Tail Moment (OTM in arbitrary units), %Tail DNA and Tail length (migration of the DNA from nucleus in micrometre). Data were collected for Tail length (micrometre) and % Tail DNA to compute OTM by software using formula OTM 5 Tail length Â % Tail DNA/100. Images from 50 cells (25 from each replicate slide) were analyzed and data presented as mean AE SE. Frequency distribution of cells with different OTM values (OTM 2.5, 5, 7.5 and !10) was computed and plotted. The personal bias in data collection was avoided using traditional random sampling method where first 25 specimens were sampled randomly from eight slides of each treatment group.
Plasmid relaxation/plasmid strand break assay Two hundred nanogram of pUC19 plasmid DNA was mixed with 175 lm H 2 O 2 , 70 lm potassium dichromate and 70 lm ascorbic acid with/without 70 lm LA in 24-ll autoclaved PBS. Suitable controls were prepared similarly and reaction mixture incubated at 37°C in dry bath for 30 min. Samples were loaded immediately on 1% agarose gel for electrophoresis (70 V, 1 h) in TAE buffer (40 mM Tris, 20 mM sodium acetate and 2 mM EDTA) (25) . Ethidium bromide (0.5 lg/ml)-stained DNA bands were visualized in Gel Documentation system Model Syngene G: 13 Box. Photo was captured by Gene Snap version 6.07 and analyzed using software Gene Tool 3.06.
Statistical analyses
Statistical significance of mean values of Tail moment, Tail DNA and Tail length in mouse lymphocytes and in different treatment groups was analyzed using one-way analysis of variance, after ascertaining the homogeneity of variance between treatment groups. Post-hoc analysis was carried out for intergroup comparisons by calculating least significant difference. The level of significance was considered to be 5%. Similar analysis was done for co-and post-toxicant administration of LA and for bone marrow cells.
Results
Oral administration of potassium dichromate caused DNA damage in PBMC. OTM, %Tail DNA and Tail length registered changes (Table I) . Change in Tail length and OTM was substantial and significant ('P' value , 0.001) at high dose. Tail length increased 4-fold, whereas OTM increased 2-fold. Effect of Cr 6þ was dose dependent. Analyses of cell frequency in total cell yield showing different extent of DNA damage (OTM, on scale of 2.5 to !10) registered similar trend (Figure 2 ). Cells showing 5 OTM harboured less DNA damage, whereas same showing !7.5 OTM as harboured great damage. In control group, cell frequency in 2.5 OTM faction was greater and was dispersed up to OTM 5. In positive control group, the same was greater in 7.5 OTM faction distributing progressively up to !10 OTM. Shifts in cell frequency within faction 2.5 to !10 demonstrated toxicity or protection and was dose dependent (Figures 2 and 3) . Maximum damage was seen with high-dose Cr 6þ . This dose was selected for studies with LA. Administration of LA resulted in considerable protection against Cr 6þ -induced DNA damage. Test parameters viz. cell frequency with damaged DNA and OTM, %Tail DNA or Tail length revealed protection. In pre-toxicant administration regimen, low, moderate or high doses of LA provided a corresponding degree of protection in studied cell types (Tables II and III) . Maximum protection was seen with highdose LA. Values of Tail moment, %Tail DNA and Tail length in this group vis-à-vis control were statistically insignificant ('P' value . 0.05). Protective effect was dose dependent and comparatively similar in PBMC or BMC. Protection was irrespective of LA administration schedule viz. pre-, co-or post-toxicant regimen. LA or vehicle alone did not set DNA damage in any of test systems and in any of administration regimen ('P' value . 0.05). In co-or post-toxicant administration regimens of LA, similar results were seen in both cell types (Tables IV-VII) .
Protective effect of LA was evident also from data on frequency of cells with damaged DNA (Figure 3 ). In pre-toxicant LA administration group, cell frequency was greater in OTM 5 faction and regressively distributed between 7.5 and 2.5 OTM, maximum frequency of cell being in OTM 2.5 and 5 faction demonstrating protection (Figure 3) . A concomitant and substantial decrease in cell frequency in OTM !10 categorically confirmed these results. Test doses of LA alone did not damage DNA. A dose-dependent protective trend of LA was seen in cell frequency harbouring damaged DNA (Figure 3 ). High dose provided maximum protection (Figure 3) . Similar pattern was seen in BMC. Co-or post-toxicant administration of LA also revealed similar results (data not shown).
DNA damage during interactions of Cr 6þ and LA are summarized in Figure 4 
Discussion
Our study showed a strong potential of LA for abrogation of Cr 6þ -induced DNA damage in both in vitro/in vivo test systems. Study revealed chemopreventive as well as chemotherapeutic value of LA. Since SCGE measured a broad spectrum of DNA damage (22) (23) (24) , these results can be understood to document abrogating potential of LA against variety of DNA damage following Cr 6þ exposure (2). Verification of cytoprotection against DNA-protein cross-link formation is available from our earlier report (19) . The fact that even the highest test dose of LA did not prevent DNA damage completely as measured by the SCGE assay could be possibly due to sub-optimal amount of the used dose and/or nonsynchronous toxicokinetics/pharmacokinetics of Cr 6þ /LA. Mechanism of protection appeared to be its antioxidant/or antioxidant-revitalizing property and metal-chelating function. (26, 27) . Reactivity of LA and/or DHLA towards reactive nitric oxide species has also been demonstrated (28) (29) (30) .
LA/DHLA redox couple regenerated other cellular antioxidants and provided protection indirectly as well. With a redox potential of À0.32 V, LA/DHLA redox couple could directly reduce GSSG to GSH (redox potential À0.24) (31). The intraperitoneal or intragastric administration of LA in rats increased GSH levels in several tissues (32) (33) (34) (35) . DHLA also reduced dehydro-ascorbate and semi-dehydroascorbyl radical (36) . LA/DHLA couple is reported to regenerate vitamin E from its oxidized form in biological systems (26, 37) . LA supplementation under various physiological and pathophysiological conditions decreases oxidative stress and restores the normal levels of other antioxidants in vivo (6, 38, 39) . Ameliorative potential of LA is proven in oxidative damage and memory loss (40, 41) .
One-electron reduction of Cr 6þ by LA and resultant OHÁ generation, dG hydroxylation and nuclear transcription factorkappab activation is described in literature (37, 42) which may be understood to advocate the Cr 6þ toxicity-aggravating potential of LA. Nevertheless, such in vitro observations could not be confirmed in literature for their physiological significance in vivo (15, 20) . Cr 6þ toxicity-aggravating potential of LA (suspected owing to reported one-electron reduction of Cr 6þ by LA) was not seen in our study. Cr 6þ caused DNA breakdown only in presence of ascorbate and H 2 O 2 , which confirmed earlier studies showing involvement of Cr 6þ metabolism and ROS generation in toxicity. Using plasmid relaxation assay LA, on the contrary showed its potential to annul the resultant DNA damage induced by interactions of ascorbate þ LA þ Cr 6þ þ H 2 O 2 . Metal toxicity is of major health concern in Cr 6þ handlers. Occupational exposure to Cr 6þ compounds (occupational carcinogens) is associated with increased risk of ulcer formation, respiratory system cancers, primarily bronchogenic and nasal in a number of studies (1) . These clinical symptoms seem to be the function of oxidative stress and possibly slow wound healing. Loss of DNA integrity and slow redoxmediated DNA repair during oxidative stress (42) could impair the cell cycle control and the onset of toxicity in Cr 6þ -exposed cells. Role of LA in DNA repair mechanism abrogating Cr 6þ -induced loss of genomic integrity requires a detailed investigation.
In conclusion, results are of nutritive/therapeutic value for mitigation of systemic Cr 6þ poisoning or reduction of occupational cancer risk in humans. The experimental therapeutic research potential of LA against Cr 6þ toxicity is advocated.
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